The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
A 57-year-old man who alleges that Cedars-Sinai Medical Center fired him as a mental health worker in 2023 for reasons related to his sleep apnea must take his claims before an arbitrator rather than ...
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
Check out this year's top 5 pieces of sleep coverage that cover topics surveying the benefits of supplements, novel ...
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough ...
More than 60 million Americans battle insomnia, and counting sheep, reading dull books or skipping naps isn't helping. Here ...
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...
A new evidence review says that coffee and tea consumption are linked to a lower risk of cancers of the mouth, throat, and head and neck, per the results published in the journal Cancer.
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback